Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)

OpuholiŽenskoj Reproduktivnoj Sistemy

D. A. Baranovsky¹  I. L. Gulyaeva²  M. V. Kiselevsky³  A. N. Gritsai³ 

[1] Department of Oncology, A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia;Department of Pathological Physiology, E.A.Vagner Perm State Medical University Ministry of Health of Russia;N.N. Blokhin Russian Cancer Research Center, Moscow;

关键词: oncopathology of the female reproductive system;    standardized morbidity rates;    chemotherapy;    radiotherapy;    adoptive immunotherapy;    natural killer cells;    lymphokine-activated killers;    mononuclear leukocytes;    tumor ascites;    ovarian cancer;    breast cancer;   

DOI  :  10.17650/1994-4098-2014-0-4-71-73

来源: DOAJ

【 摘 要 】

The review highlights current approaches to adoptive immunotherapy in patients with malignant neoplasms of the female reproductive system.In spite of the obvious advances made by scientists of the world in treating malignant neoplasms, the existing treatment options remain insufficiently effective. To search for novel highly effective and safe treatments is an urgent problem of oncology. Adoptive immunotherapy is one of the priorities in this regard.

【 授权许可】

Unknown